目錄:愛必信（上海）生物科技有限公司>>生化試劑>>小分子化合物>> abs810002SB 203580
| 參考價(jià) | ￥331-￥1682 |
參考價(jià)：￥331 ~ ￥1682
5mg 10mg 100mg
CAS:152121-47-6 純度:＞98% 分子量:377.44 分子式:C21H16FN3OS 供貨周期:現(xiàn)貨 規(guī)格:5mg;10mg;100mg 貨號(hào):abs810002 應(yīng)用領(lǐng)域:化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 主要用途:-
>| 5mg | 331元 | 999mg可售 |
| 10mg | 403元 | 999mg可售 |
| 100mg | 1682元 | 999mg可售 |
更新時(shí)間：2025-10-29 15:42:37瀏覽次數(shù)：2098評(píng)價(jià)
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息，謝謝!
| CAS | 152121-47-6 | 純度 | ＞98% |
|---|---|---|---|
| 分子量 | 377.44 | 分子式 | C21H16FN3OS |
| 供貨周期 | 現(xiàn)貨 | 規(guī)格 | 5mg;10mg;100mg |
| 貨號(hào) | abs810002 | 應(yīng)用領(lǐng)域 | 化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 |
| 主要用途 | - |
| 產(chǎn)品描述 | |
| 描述 | SB 203580是一種p38 MAPK抑制劑，在THP-1細(xì)胞中IC50為0.3-0.5μM，對(duì)SAPK3(106T)和SAPK4(106T)選擇性低10倍，且阻斷PKB磷酸化，IC50為3-5μM。SB203580是第一個(gè)被報(bào)道的p38抑制劑。 |
| 純度 | ＞98% |
| 儲(chǔ)存/保存方法 | Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | Adezmapimod；RWJ 64809 |
| 外觀 | white to off-white powder |
| 可溶性/溶解性 | DMSO：43 mg/mL (113.92 mM) |
| 生物活性 | |
| 靶點(diǎn) | p38 MAPK；PKB |
| In vitro(體外研究) | SB 203580 inhibits the IL-2-induced proliferation of primary human T cells, murine CT6 T cells, or BAF F7 B cells with an IC50 of 3–5 μm. SB203580 also inhibits IL-2-induced p70S6 kinase activation, although the concentration required is slightly higher with an IC50 above 10 μm. SB203580 also inhibits the activity of PDK1 in a dose-dependent manner with an IC50 in the 3–10 μm range. SB203580 inhibits p38-MAPK stimulation of MAPKAPK2 with an IC50 of approximately 0.07 μM, whereas inhibits total SAPK/JNK activity with an IC50 of 3–10 μM. SB203580 at higher concentrations activates the ERK pathway, which subsequently enhances NF-κB transcriptional activity. SB203580 induces autophagy in human hepatocellular carcinoma (HCC) cells. |
| In vivo(體內(nèi)研究) | SB203580 protects pig myocardium against ischemic injury in an in vivo model. SB203580 is effective to prevent and treat the disease in MRL/lpr mice model of Systemic lupus erythematosus (SLE). |
| 研究領(lǐng)域 | |
| 研究領(lǐng)域 | ImmunologyInnate ImmunityTLR Signaling NeuroscienceDevelopment NeuroscienceProcesses Signal TransductionProtein PhosphorylationSer / Thr KinasesMAPK Pathway Drug DiscoverySmall Molecule DrugLead Compound Discovery |
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)
會(huì)員.png)
10
化工儀器網(wǎng)